Skip to Content

SEC Filing

Document Details

Filing Date
Mar 4, 2024
Document Date
Mar 4, 2024
Form Description
Solicitation/recommendation statements
Filing Group
Mergers & Acquisitions
Company
Kinnate Biopharma
Issuer
Kinnate Biopharma Inc.